(Q42617986)

3 November 2017

Hepatitis C virus and human immunodeficiency virus: clinical issues in coinfection (English)

1 reference

3 November 2017

1 reference

1 reference

D T Dieterich

1

1 reference

PubMed ID

10653464

3 November 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

American Journal of Medicine

3 November 2017

1 reference

3 November 2017

107

1 reference

3 November 2017

6B

1 reference

3 November 2017

79S-84S

1 reference

Investigation of chronic hepatitis C infection in individuals with haemophilia: assessment of invasive and non-invasive methods

3 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900390-3

A review of hepatitis C virus (HCV) vertical transmission: risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900390-3

Hepatitis C virus infection in the mothers and infants cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900390-3

Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900390-3

Hepatitis C virus infection in patients infected with the human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900390-3

Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900390-3

The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900390-3

Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900390-3

Hepatotoxicity after introduction of highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900390-3

Hepatomegaly with severe steatosis in HIV-seropositive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900390-3

Ribavirin antagonizes the effect of azidothymidine on HIV replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900390-3

A phase-I study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease. AIDS Clinical Trials Group 231 Protocol Team.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900390-3

Drug sensitivity of human immunodeficiency virus type 1 isolates after ribavirin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900390-3

Liver biopsy findings in 501 patients infected with human immunodeficiency virus (HIV).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900390-3

Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900390-3

Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative-strand viral RNA in various tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900390-3

10.1016/S0002-9343(99)00390-3

7 January 2021

Identifiers

DOI

1 reference

3 November 2017

1 reference

PubMed ID

10653464